Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunresin is a China-based publicly traded advanced materials and separation technology company that develops, manufactures, and sells adsorption, ion-exchange, and chromatography resins, along with integrated process equipment and technical services. While it is not a therapeutics developer, it has a meaningful healthcare and life sciences business through purification media and process solutions used in pharmaceuticals, biotechnology, peptide and oligonucleotide synthesis, and monoclonal antibody manufacturing. The company markets life-science products through its chromatography and synthesis resin lines, including Protein A and other purification media, and has been expanding dedicated global life-sciences operations. Sunresin also serves non-healthcare end markets such as water treatment, food, environmental protection, chemicals, and metals recovery. For a biotech analyst, the company is best understood as a commercial-stage bioprocess materials and downstream purification supplier rather than a drug pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunresin New Materials.